Differential Graft Resistance of C3H Mice Prztreated with Antitumor Drugs Against Balb/C Bone Marrow or Lymphoma Cells

References

• Cudkowicz G., Bennett M. Peculiar imunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J. Exp. Med. 1971; 134: 83
   PubMed Web of Science ®Google Scholar
• Cudkowicz G., Bpnnett M. Peculiar immunobiology of bone marrow allografts. II. Rejection cf parental grafts by resistant F1 hybrid mice. J. Exp. Med. 1971; 134: 1513
   PubMed Web of Science ®Google Scholar
• Cudkowicz G., Lotzova E. Hemopoietic cell-defined components of the major histocompatibility complex of mice: identification of responsive and unresponsive recipients for bone marrow transplants. Transplant. Proc. 1973; 5: 1399
   PubMedGoogle Scholar
• Cudkowicz G. Genetic control of resistance to allogeneic and xenogeneic bone marrow grafts in mice. Transplant. Proc. 1975; 7: 155
   PubMedGoogle Scholar
• Bonmassar E., Cudkowicz G. Suppression of allogeneic lymphomas in spleens of irradiated mice. Importance of the D-end of the H-2 complex. J. Immunol. 1976; 117: 597
   PubMedGoogle Scholar
• Iorio A. M., Campanile F., Neri M., Spreafico F., Goldin A., Bonmassar E. Inhibition of allogeneic lymphoma growth in the spleen and liver of lethally irradiated mice. J. Immunol. 1978; 120: 1679
   PubMedGoogle Scholar
• Bonmassar E., Riccardi C., Campanile F., Iorio A. M., Puccetti P., Herberman R. B. Radioresistant inhibition of tumors (RIT): Biological and pharmacological studies. Current Trends in Tumor Immunology, S. Ferrone, R. B. Herberman, S. Gorini, R. A. Reisfeld. Garland Publishing Co., Inc., New York 1979; 49
   Google Scholar
• Bonmassar E., Campanile F., Houchens D., Crinò L., Goldin A. Impaired growth of a radiation induced lymphoma in intact or lethally irradiated allogeneic athyllic (nude) mice. Transplantation 1975; 20: 343
   PubMedGoogle Scholar
• Campanile F., Crinò L., Bonmassar E., Houchens D. P., Goldin A. Radioresistant inhibition of lymphoma growth in congenitally athymic (nude) mice. Cancer Res. 1977; 37: 394
   PubMedGoogle Scholar
• Glynn J. P., Bianco A. R., Goldin A. Studies on induced resistance against iso-transplants of virus induced leukemia. Cancer Res. 1964; 24: 502
   PubMed Web of Science ®Google Scholar
• Hofer K. G., Hughes L. Incorporation of Iodo-deuxyuridine-125I into the DNA of L1210 leukemia cells during tumor development. Cancer Res. 1970; 30: 236
   PubMed Web of Science ®Google Scholar
• BeMett M. Rejection of marrow allografts. Importance of H-2 homozygosity of donor cells. Transplantation 1972; 14: 289
   PubMedGoogle Scholar
• Anderson R. E., Warner N. L. Ionizing radiation and the immune response. Adv. in Immunol. 1976; 24: 215
   PubMedGoogle Scholar
• Vecchi A., Fioretti M. C., Mantovani A., Barzi A., Spreafico F. The imunodepressive and hematotoxic activity of 5–(3, 3′-diethyl-1-triazeno)-imidazole-4-carboxamide in mice. Transplantation 1976; 22: 619
   PubMed Web of Science ®Google Scholar
• Giampietri A., Bonmassar E., Goldin A. Drug induced modulation of immune responses in mice: effects of 5–(3, 3′-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC) and Cyclophosphamide. J. of Snnnunopharmacology 1978–79; 1: 61
   PubMedGoogle Scholar
• Stockmann G. D., Heim L. R., Souch M. A., Trentin J. J. Differential effect of cyclophosphamide on the B and T cell compartments of adult mice. J. Immunol. 1973; 110: 277
   PubMed Web of Science ®Google Scholar
• Milton J. T., Carpenter C. B., Addison I. E. Depressed T-cell reactivity and suppressor activity of lymphold cells from cy-clophosphamide-treated mice. Cell. Immunol. 1976; 24: 308
   PubMedGoogle Scholar
• Turk J. L., Parker D. The effect of cyclophosphamide on the immune response. J. Immunopharmacol. 1979; 1: 127
   PubMedGoogle Scholar
• Cudkowicz G. Genetic control of bone marrow graft rejection. I. Determinant specific difference of reactivity in two pairs of inbred mouse strains. J. Exp. Med. 1971; 134: 281
   PubMedGoogle Scholar
• Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv. Cancer Res. 1978; 27: 305
   PubMedGoogle Scholar
• Herberman R. B., Djeu J. Y., David H., Kay Y., Oraldo J. K., Riccardi C., Bonnard G. D., Holden H. T., Fagnani R., Santoni A., Puccetti P. Natural killer cells. characteristics and regulation of activity. Immunological Rev. 1979; 44: 43
   Google Scholar
• Kiessling R., Wigzell H. An analysis of murine NK cells as to structure, function and biological relevance. Immunological Rev. 1979; 44: 166
   Google Scholar
• Hibbs J. B. The macrophage as a tumorcidal effector cell: A review of in vivo and in vitro studies on the mechanism of the activated macrophage non-specific cytotoxic reaction. The Macrophage in Neoplasia, M. A. Fink. Academic Press, New York 1976; 83–111
   Google Scholar
• Keller R. Cytostatic and cytocidal effects of activated non-immune macrophages. The Macrophage in Neoplasia, M. A. Fink. Academic Press, New York 1976; 149–164
   Google Scholar
• Adam D. O., Snyderman R. Do macrophages destroy nascent tumors? J. Natl. Cancer Inst. 1979; 62: 1341
   Google Scholar
• Herberman R. B., Holden H. T. Natural killer cells as antitumor effector cells. J. Natl. Cancer Inst. 1979; 62: 441
   PubMed Web of Science ®Google Scholar
• Kiessling R., Hochman P. S., Haller O., Shearer G. M., Wigzell H., Cudkowicz G. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur. J. Immunol. 1977; 7: 655
   PubMed Web of Science ®Google Scholar
• Cudkowicz G., Hochman P. S. Do natural killer cells engage in regulated reaction against self to ensure homeostasis. Immuno-logical Rev. 1979; 44: 13
   PubMed Web of Science ®Google Scholar
• Herberman R. B. Cell mediated immunity to tumor cells. Adv. Cancer Res. 1974; 19: 207
   PubMedGoogle Scholar
• Loo T. L., Tanner B. B., Householder G. E., Shepard B. J. Some pharmacokinetic aspects of 5–(dimethyl-triazeno)-imidazole-4-cnrboxamide in the dog. J. Pharm. Sci. 1968; 57: 2126
   PubMedGoogle Scholar
• Riccardi C., Puccetti P., Sautoni A., Herbennan R. B., Bon-Massar E. Adriamycin-induced antitumor response in lethally irradiated mice. Immunopharmacology 1979; 1: 211
   PubMedGoogle Scholar
• Schultz R. M., Paulidis N. A., Chirigos M. A., Weiss J. F. Effects of whole body x-irradiation and cyclophosphamide treatment on induction of tumorcidal functions in mice. Cell. Immunol. 1978; 38: 302
   PubMedGoogle Scholar